# Aortic Valve Neocuspidization With Glutaraldehyde-Treated Autologous Pericardium (Ozaki Procedure)

> **NCT05411055** · — · ACTIVE_NOT_RECRUITING · sponsor: **Maria Cecilia Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Aortic Valve Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05411055
- **Lead sponsor:** Maria Cecilia Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-06
- **Primary completion:** 2026-06-06
- **Final completion:** 2027-06-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05411055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05411055, "Aortic Valve Neocuspidization With Glutaraldehyde-Treated Autologous Pericardium (Ozaki Procedure)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05411055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*